Europe Breast Cancer Therapeutics Market Analysis

Europe Breast Cancer Therapeutics Market Analysis

$ 3999

The Europe breast cancer therapeutics market size was valued at $3.45 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 11.64% from 2022 to 2030 and will reach $8.34 Bn in 2030. The main factors propelling the Europe breast cancer market are the implementation of breast cancer screening programs and increased research and development initiatives for new drug developments in Europe. The market is segmented by therapy, by cancer type, and by distribution channel. Mylan, AstraZeneca, and Celltrion are some of the main market players in the Europe breast cancer therapeutics market.

ID: IN10EUPH031 CATEGORY: Pharmaceuticals GEOGRAPHY: Europe AUTHOR: Parul Choudhary

Buy Now

Europe Breast Cancer Therapeutics Market Executive Analysis

The Europe breast cancer therapeutics market size is at around $3.45 Bn in 2022 and is projected to reach $8.34 Bn in 2030, exhibiting a CAGR of 11.64% during the forecast period. More than any other EU Member State, current healthcare spending in Germany and France was comparable to 12.8% and 12.2% of GDP, respectively. Austria (11.5%), Sweden (11.4%), the Netherlands (11.1%), and Belgium (11.1%) had the next-highest rates. Only three other EU members, Spain, Portugal, and Denmark, had double-digit rates. 11.8% of Switzerland's GDP is being spent on healthcare, while Norway likewise has a double-digit ratio. In comparison, less than 7.5% of GDP was spent on current healthcare in six Member States, with Luxembourg having the lowest %age (5.8%).

The European Cancer Information System (ECIS) forecasts that breast cancer will continue to be the most prevalent cancer in women, accounting for 29.2% of all malignancies in females in the European Union (EU-28). A total of 404,920 new cases of female breast cancer were predicted to be diagnosed in the EU-28 nations in 2018, translating to an age-adjusted standardized rate (ASR) of 144.9/100,000. Less than 5% of occurrences of breast cancer occur in those under the age of 35, whereas 75% of cases affect adults over the age of 50. With a median age of 41.9 years compared to a global median age of 29.2 years, demographic trends in Europe indicate an aging population. The burden of breast cancer and its effects on public health will continue to rise as the EU's population ages. To provide the most individualized, secure, and effective therapy, treatment options are dependent on the grade, stage, and breast cancer molecular subtype. The grade reflects how tumor cells differ from normal cells in terms of appearance. In order to treat non-metastatic breast cancer, the tumor is removed completely or with breast preservation surgery, followed by systemic therapy such as chemotherapy and targeted therapy, as well as preoperative (neoadjuvant) or postoperative (adjuvant) radiotherapy. Endocrine therapy for hormone receptor-positive (HR+) breast cancer and anti-HER2 therapy for HER2+ breast cancer make up targeted therapy. For the triple-negative breast cancer subtype, there is sadly no available targeted therapy.

europe breast cancer therapeutics market analysis

Market Dynamics

Market Growth Drivers

The development of the Europe breast cancer therapeutics market is anticipated to be aided by the implementation of breast cancer screening policies and programs to reduce the incidence and mortality rates related to the disease. The demand for the Europe breast cancer therapeutics market is also expected to rise in parallel with variables that support drug development, such as increased R&D spending and oncology developments.

Market Restraints

The primary inhibitor of the Europe breast cancer therapeutics market is the patent expiration of certain medications. The expansion of the Europe breast cancer therapeutics market is also hampered by strict guidelines and regulations, as well as the side effects of chemotherapy.

Competitive Landscape

Key Players

  • Mylan
  • AstraZeneca
  • Celltrion
  • Bristol-Myers Squibb
  • Fresenius Kabi
  • Eisai
  • Baxter Healthcare
  • GlaxoSmithKline

Healthcare Policies and Regulatory Landscape

Countries in Europe have created a variety of reimbursement methods or policy tools to build their benefits packages. The product-specific eligibility model, which gives priority to specific medications and their indications, is the most widely used method. Mixed models are frequently created to address the protection of those who are more vulnerable, ensure protection against cancer-related poverty, and reduce inequities. Generally speaking, public health insurance programs in the majority of European nations cover the cost of breast cancer screening, diagnosis, and treatment, for example, all eligible persons in the UK are covered by the National Health Service for the cost of breast cancer screening, diagnosis, and treatment.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Breast Cancer Therapeutics Segmentation

By Therapy (Revenue, USD Billion):

  • Radiation Therapy
    • Targeted Therapy
      • Ribociclib
      • Abemaciclib
      • Afinitor
      • Everolimus
      • Trastuzumab
      • Olaparib
      • Ado-Trastuzumab Emtansine
      • Palbociclib
      • Pertuzumab
      • Herceptin
      • Tykerb (Lapatinib)
      • Others
  • Hormonal Therapy
    • Selective Estrogen Receptor Modulators (SERMs)
    • Aromatase Inhibitors
    • Estrogen Receptor Downregulators (ERDs)
  • Chemotherapy
    • Taxanes
    • Anthracyclines
    • Anti-metabolites
    • Alkylating Agents
  • Immunotherapy

By Cancer Type (Revenue, USD Billion):

  • Hormone Receptor
  • HER+

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 23 April 2024
Updated by: Shivam Zalke

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter